Journal of Oncology Pharmacy Practice

Article	Citations
Practical considerations in the management of patients with atrial fibrillation/flutter and hematologic malignancies	24
Mercaptopurine induced myelosuppression in a child with a NUDT15 rs116855232 homozygous variant	19
Temporal effect of imatinib adherence on time to remission in chronic myeloid leukemia patients	18
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient	17
Premedication strategy in cetuximab rechallenge after Grade 2 hypersensitivity reactions	17
Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy	17
Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers	15
Rituximab-induced severe acute thrombocytopenia in a patient with splenic marginal zone lymphoma	14
Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients	13
A room of errors simulation to improve pharmacy operators’ knowledge of cytotoxic drug production	13
Clinical characteristics and risk factors for oxaliplatin hypersensitivity reactions in patients with colorectal cancer	12
Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP)	12
Safety and efficacy of Vitamin C, Vitamin E, and selenium supplementation in the oncology setting: A systematic review	12
Post COVID availability of oncology drugs – Is this the new normal on both sides of the Atlantic?	12
Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors	12
Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies	12
Identifying health disparities in lenalidomide access	11
Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice	11
Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center	11
Initial real-world experience with ribociclib in advanced breast cancer	11
Exploring the potential relationship between antineoplastic agents and their association with stomatitis and oral candidiasis in cancer patients	10
Nivolumab–ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment	10
Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantation	10
Assessment of chemical contamination by cancer drugs during use of the RIVA TM compounding robot: A pilot study	10
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer	10

Evaluation of proteinuria monitoring practice patterns and treatment implications in patients with cancer receiving bevacizumab products	10
Use of two general-purpose scales to assess clinical pharmacy activities in a cell transplantation unit	9
Attitude of healthcare professionals toward the use of complementary and alternative medication during anti-cancer therapy	9
Acute pancreatitis associated with pembrolizumab-induced hypertriglyceridemia	9
Antiandrogen therapies: Management of drug interactions with anticoagulation	9
CAPhO Conference 2024 Abstract Book	9
Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy Assembly	9
Estimation of financial burden of breast cancer and its effect on quality of life	8
Clinical uses and safety concerns of tyrosine kinase inhibitors with a focus on novel drugs: A narrative review	8
Evaluating aggressiveness of end-of-life care in patients with advanced cancer: A retrospective single-center analysis	8
Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer	8
Recurrent and atypical immune checkpoint inhibitor-induced pneumonitis	8
Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review	8
Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant	8
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant	8
Gemcitabine-associated DRESS syndrome: A case report	8
Immunotherapy “stop and go” and early discontinuation: A viable option in limited resources setting	8
Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactions	8
Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer	7
Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study	7
CAPhO Conference 2026 Abstract Book	7
Continuous versus intermittent tacrolimus for graft-versus-host disease prophylaxis in pediatric hematopoietic stem cell transplantation patients (Tic Tac)	7
Risk-based analytical quality control of chemotherapy preparations: A simulation and FMECA approach	7
Innovation in hospital pharmacy: Modeling the installation of automated dispensing systems based on an oncology hospital experience transfer	7
Risk assessment of pneumatic tube systems for in-hospital transportation of biotherapeutics	7
The inpatient oncology pharmacist experience in the era of temporary oncologists	7
Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin	7
Pharmacist-led anticoagulation care in cancer: Associations with bleeding and VTE recurrence	7
Retrospective cross-sectional study of drug utilisation and expenditure of anticancer drugs at zonal referral hospital central, Tanzania	7
Pembrolizumab induced type 1 diabetes mellitus in a patient with metastatic melanoma and literature review on steroids as a treatment option	7
Safety and efficacy of efbemalenograstim alfa for chemotherapy-induced neutropenia: A systematic review and meta-analysis of randomized controlled trials	7
Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing	7
Activated carbon adsorption sheets suppress volatilization of anticancer drugs excreted in urine, preventing environmental contamination and human exposure	7
Hepatic sinusoidal congestion associated with inotuzumab therapy in patients with B-cell acute lymphoblastic leukemia, a proposal for a new clinical entity: Calicheamicin syndrome	7
Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia	7
Antimicrobial prophylaxis in pediatric patients with leukemia: Reducing incidence of febrile neutropenia episodes and bloodborne infections	7
Pembrolizumab related perforated appendicitis	6
Capecitabine-related neurotoxicity presenting with agraphia	6
Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome	6
Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar	6
Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)	6
Sacituzumab govitecan in breast cancer patients – an evaluation of progression-free survival, overall survival, and hypersensitivity reactions in real-world patients	6
Adverse drug reactions associated with doxorubicin and epirubicin: A descriptive analysis from VigiBase	6
Safety and tolerability of adjuvant combination treatments following KEYNOTE-522 for early-stage or locally advanced breast cancer with residual disease	6
Rapid drug desensitization to taxanes: a descriptive study from Turkey	6
Intravenous route for folate supplementation in a patient with celiac disease treated by pemetrexed-based chemotherapy for non-small-cell lung cancer	6
Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments	6
Anti-cancer drug waste disposal practices and wastewater management in hospitals: A Lebanese survey	6
Safety of alisertib in the treatment of solid and hematological cancers: A systematic review and meta-analysis of randomized controlled trials	6
Pharmacist's role in the management of drug–drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients	6

Identifying risk factors of dose reduction or treatment discontinuation due to fatigue or gastrointestinal symptoms in patients receiving lenvatinib treatment for hepatocellular carcinoma	6
Medical marijuana in the treatment of cancer-associated symptoms	6
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant	6
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes	6
Predictors of fluid overload in allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide	6
Usefulness of hydrocortisone prophylaxis for oxaliplatin-induced hypersensitivity reactions: A retrospective study	6
Feasibility study of an innovative simulation-based learning program in hospital oncology pharmacy: A pilot project in a faculty of pharmacy	6
Efficacy and safety of adjuvant capecitabine and pembrolizumab in early-stage triple-negative breast cancer after standard neo-/adjuvant chemotherapy: A meta-analysis of phase III studies	6
Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution	5
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review	5
Evaluating patients on immune checkpoint inhibitors for cardiac adverse events: The EPICC study	5
Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents	5
Real-world experience of abemaciclib for adjuvant and metastatic breast cancer	5
Hypersensitivity reaction to Abiraterone, successful desensitization protocol in prostate cancer patient	5
Real-world effectiveness of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and advanced melanoma at BC Cancer	5
Investigating effective methods of clinical pharmacy training on oncology for community pharmacists: An observational study	5
Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series	5
Effectiveness of antiemetic in reducing chemotherapy-induced nausea and vomiting in adult patients; An oncology center experience	5
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer	5
Cytotoxic surface contamination in hospitals: Current practices, challenges and perspectives	5
Misalignment between patient preferences and clinician expectations: Do press releases make clinicians impatient to the detriment of patients?	5
Oral anticancer medicine interventions: A cross-sectional study in French community pharmacies	5
Author responseIn response to: JOPP-26–0271The French Society for Oncology Pharmacy commentary on Iannopollo M., J Oncol Pharm Pract, 2026	5
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies	5
Acute infusion-related reactions in pediatric patients receiving etoposide at a tertiary cancer center	5
An assessment of the prevalence of drug therapy problems and its associated factors among ovarian cancer patients at Kenyatta National Hospital	5
Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate	5
Medication errors in an oncology inpatient setting in India—Audit by clinical pharmacists	5
Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism	5
Safety and oncological effectiveness after desensitization in patients with previous hypersensitivity reactions to chemotherapy	5
Examining clinical pharmacist interventions and identifying opioid medication-related issues in patients with cancer	5
Retrospective study on the efficacy and tolerability of dose modification of PD-1 and PD-L1 inhibitors in hospital-system community outpatient cancer clinics	5
Immune checkpoint inhibition in advanced colorectal cancer with inherited and acquired microsatellite instability: Current state and future directions	5
Corrigendum to Audit on Oral Systemic Anti-Cancer Therapies (SACT) Adherence Using the Morisky Medication Adherence Scale (MMAS): Implications for Pharmacy Counselling	4
Residual contamination in antineoplastic drug packaging	4
Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital	4
Bilateral epithelial keratopathy and punctate keratitis due to ribociclib	4
Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case	4
Carboplatin dosing in obese patients	4
Therapeutic potential of phytoconstituents in oncocosmetics: A systematic review on radiodermatitis management	4
Oncology stewardship: A narrative review of principles and practices	4
The effect of examining somatic alterations with NGS in patients with solid tumors, on patient management: A single-center experience in Turkey	4
Time-saving impact of two generation model chemotherapy compounding robots on pharmacists’ daily workflow: A long-term evaluation	4
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia	4
Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemothera	4
Meperidine compared to morphine for rigors associated with monoclonal antibody-related infusion reactions	4
Perceptions and prevalence of marijuana use among cancer patients managed at an outpatient department in Zimbabwe: A brief report	4
Hypersensitivity reactions to chemotherapy and biologics: Outcomes and safety of 927 desensitization in Mexico	4
The effect of Bevacizumab treatment on the incidence of hypertension in patients with ovarian cancer: a systematic review and meta-analysis	4
Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method	4
Laryngopharyngeal dysesthesia as a possible clinical manifestation of a cytokine release reaction due to oxaliplatin	4
Chronic cannabis use in breast cancer survivors: A questionnaire study of Israeli patients	4
Managing suspected myasthenia gravis and myositis induced by pembrolizumab in a Jehovah's Witness sarcoma patient	4
Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis	4
A prospective analysis of efficacy of dexamethasone-sparing antiemetic regimens in high and moderate emetogenic chemotherapy	4
Factors affecting medication adherence in patients using oral chemotherapy: A descriptive study	4
A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance	4
Knowledge, attitudes, and practices among oncology pharmacists on cytotoxic drug reconstitution in Sri Lanka: A cross-sectional study	4
The role of the pharmacist in the hospital discharge of cancer patients: an integrative review	4
Advancements in the use of nanopharmaceuticals for cancer treatment	4
Assessment of chemotherapy dosing and regimen optimization in geriatric oncology patients diagnosed with solid organ malignancies	4
Factors associated with potentially inappropriate medications in elderly with multiple myeloma	4
Automated chemotherapy compounding: Process optimization for the preparation of admixture containing high-dose of cyclophosphamide	4
Imatinib mesylate-induced acute hepatotoxicity	4
Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices	4
Oncology pharmacy practice in Nepal: Integration, challenges, and policy directions	4
Central line-associated Rhizobium radiobacter bloodstream infection in two allogeneic hematopoietic cell transplant recipients	4
Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot study	4
Safety evaluation of outpatient ifosfamide regimens in adult sarcoma patients	4
Overcoming language barriers to enhance pharmaceutical care: Design and validation of a pictogram-based tool for cancer patients	4
Concern regarding “A novel decision tree for performing risk assessments of biologics in a health-system setting”	4
Workflow evaluation of environmental contamination with hazardous drugs during compounding and administration in an UK hospital	4
Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: An integrative review	4
Nivolumab-induced pneumonitis and cardiopathy in a patient with relapsed Hodgkin's lymphoma	4
Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer	4
Midostaurin-Associated acute pancreatitis	4
Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study	4
Pirtobrutinib: A novel non-covalent BTK inhibitor for the treatment of adults with relapsed/refractory mantle cell lymphoma	4
ISOPP International Symposium 2026 Abstracts	4
Safe handling of hazardous drugs	4

Comment on ‘risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy’	4
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring	4
Cabozantinib-induced heart failure	4
Exploring the toxicity and clinical outcomes of doxorubicin, cyclophosphamide, and taxane-based chemotherapies in women with breast cancer in Bangladesh	4
Investigation of the frequency of bortezomib neuropathy in patients with multiple myeloma diagnosis with normal and abnormal genetic characteristics	4
Rechallenges without desensitization following platinum-based chemotherapy reactions	3
Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis	3
Real world comparison of filgrastim to filgrastim-sndz in patients with chemotherapy-induced neutropenia	3
Pharmacist interventions in optimising opioid medication therapy in pain management for palliative care patients: A systematic review	3
Correlation between lymphocyte counts and PD-L1 immune-related adverse events	3
Manual versus automated chemotherapy preparation: A retrospective pharmaco-economic analysis	3
Redispensing of expensive oral anticancer medicines: A practical application	3
Impact of obesity on doxorubicin pharmacokinetics in women with breast cancer	3
Optimizing intermittent dosing of oral small molecule inhibitors	3
Anti-cancer medicine shortages in an oncology tertiary hospital of Pakistan: A five-year retrospective study	3
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma	3
Incidence of invasive fungal infections in patients with chronic lymphocytic leukemia receiving ibrutinib within the veteran’s healthcare administration	3
A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure	3
Impact of healthcare providers’ training (ISOPP-OPAB) on biosimilars use for cancer care at a university hospital in Nigeria	3
Tamoxifen induced maculopathy presenting like macular telangiectasia type 2 in a patient with breast cancer	3
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia	3
Implementation of Partnered Pharmacist Medication Charting in haematology and oncology inpatients	3
Increased alanine aminotransferase level as a predictive marker of hand-foot syndrome in patients receiving capecitabine: A retrospective cohort study	3
Nutrition support pharmacy practices in hospitalized cancer patients admitted to bone marrow transplant units: A 3-year retrospective analysis of clinical nutrition support pharmacists’ interventions	3
Antithrombotic and hemostatic stewardship: Evaluation of romiplostim for treatment of thrombocytopenia at a large academic medical center	3
Effects of scalp lotion containing alpha lipoic acid derivatives for chemotherapy-induced alopecia in patients with gastrointestinal cancer: A prospective cohort study	3
Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients	3
A comprehensive study of adverse effects of chemotherapy on female breast cancer patients in NORI Cancer Hospital, Islamabad in a developing country	3
Vinorelbine-related tetraplegia due to severe peripheral neuropathy	3
The relationship between immune-related adverse events during ipilimumab monotherapy and survival outcomes among melanoma patients: A systematic review	3
Efficacy of pegfilgrastim in preventing febrile neutropenia during DCF chemotherapy for esophageal cancer: A systematic review and meta-analysis	3
Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units	3
Development of an African paediatric oncology pharmacy curriculum: A SIOP Africa 2024 pharmacy workshop output	3
A critical appraisal of South African oncology pharmacy standards: A comparison with international best practice standards	3
A study to quantify knowledge obtained during the British Oncology Pharmacy Association (BOPA) Introduction to Oncology (ITO) Course	3
Tolerability and safety of extemporaneously prepared oral methotrexate suspension in pediatric acute lymphoblastic leukemia: Experience from a comprehensive cancer center in Jordan	3
Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel	3
Pharmacist-led pre-infusion screening using absolute lymphocyte count and neutrophil-to-lymphocyte ratio before immune checkpoint inhibitor therapy: A practice proposal	3
Oncology pharmacy staffing survey across practice settings in the United States	3
Overview of working conditions in pharmacy technology units: A professional evaluation in five French healthcare institution	3
Drug extravasation with Enfortumab vedotin	3
Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myeloma	3
Selinexor for the treatment of patients with relapsed or refractory multiple myeloma	3
Cycle-dependent eosinophilia due to adjuvant nivolumab for malignant melanoma	3
Acquired angioedema late in the course of nivolumab treatment	3
Vomiting of oral medications by pediatric patients: Survey of medication re-dosing practices in pediatric oncology and stem cell transplant centers	3
Implementation of a pharmacist-guided pharmacogenomics dosing service at a rural NCI-designated comprehensive cancer center	3
Oncology stewardship: Role of the pharmacists for contribution in low and middle-income countries	3
Assessment of potential drug–drug interactions in hospitalized cancer patients	3
Evaluating the clinical benefit of pembrolizumab as a first-line agent in advanced solid tumors: A comprehensive review	3
Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism	3
Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab	3
Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer	3
One patient, one order? analyzing prescription volume in oncology opioid stewardship	3
Safety outcomes of teclistamab accelerated dose escalation	3
Evaluating the efficacy of a premedication regimen including high-dose cetirizine in reduction of hypersensitivity reactions to paclitaxel: A retrospective cohort study	3
Cytomegalovirus viremia and hepatitis B reactivation in patient with RET fusion-positive non-small cell lung cancer treated with pralsetinib	3
CyFRASS-TR: A practical clinical predictive model for acute irinotecan-induced toxicity to enhance patient safety in solid tumor management	3
Evaluating the impact of a pharmacist-led venetoclax ramp-up clinic for chronic lymphocytic leukemia patients: A retrospective chart review	3
Reduced initial Pazopanib dosing strategy for recurrent, advanced, or metastatic sarcoma: A single center experience	3
Assessment of adverse drug reactions among acute myeloid leukaemia patients at Kenyatta National Hospital	3
Exploring an enhanced role of the pharmacy technician in cancer services within the uk independent sector	3
Implementation of pharmaceutical care service to elderly cancer patients in a tertiary care hospital in South India	3
Enhancing access to expensive oncology medications in Pakistan: The critical role of pharmaceutical patient assistance programs in oncology care	3
Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy, subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal	3
Overcome Daratumumab’ severe reaction with desensitization in relapsed multiple myeloma	3
Infectious complications associated with tocilizumab following chimeric antigen receptor T-cell therapy	3
Contamination on the external surface of hazardous drug vials wrapped in Vial Protect Pack shrink tack labels	3
Burden and clinical impact of chemotherapy-induced adverse drug reactions: A prospective observational study	3
Corrigendum to Role of sacituzumab govitecan in solid tumors	3
Implementation of a comprehensive medication management service for radioiodine therapy patients at an oncology hospital in Rio de Janeiro	3
A fully validated HPLC-UV detection method associated with color variation control for the evaluation of the long term stability of calcium levofolinate solutions in polyolefin infusion bags and in po	3
Safe administration of temozolomide in end-stage renal disease patients	3
New-onset persistent hyperglycemia with initiation of brentuximab treatment	3
Impact of telephone follow-up on hepatocellular carcinoma patients receiving oral chemotherapy from an ambulatory-care setting	3
A simple and inexpensive method to monitor and minimize exposure from manipulation of cytotoxic drugs	3
An assessment of exposed syringe inner walls as a route of exposure from hazardous drugs	3
Predictive risk factors associated with cancer therapy-related cardiac dysfunction: A retrospective cohort study	3
Diagnosis and management of immune checkpoint inhibitor-associated adrenal insufficiency: A single-institution experience	3
Artificial intelligence-based muscle analysis risk assessment of treatment-related toxicity in metastatic colorectal cancer	3
Patterns and predictors of antidepressant prescribing among adults with cancer and depression in ambulatory care settings in the United States	3
Optimizing antimicrobial prophylaxis strategies in acute leukemia patients: Assessing the efficacy of fluconazole	3
Oncology stewardship practice in the United States: A Hematology/Oncology Pharmacy Association national survey	3
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions	3